NEW YORK (GenomeWeb News) – Pressure Biosciences said today that it has struck a co-marketing and distribution pact with UK-based Constant Systems that will enable the companies to offer each other's products in North America and Europe.

Under the agreement, Pressure Bio will receive non-exclusive rights to market, sell, and distribute CS's high-pressure cell disruption equipment and consumables in the US, Canada, and Mexico.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: genomic study of group B Streptococcus evolution, selection on the X chromosome in great apes, and more.

Changing the fat and fiber content of people's diets affects their gut microbiome, metabolome, and colon cancer risk, researchers say.

Broken links are found throughout academic publications, and some services are trying to combat such link decay.

Nick Stockton at Wired says that a pause in studying genome-editing tools should be used to find a path forward.